Member Info for Andyken

2m prescriptions for the drug.

We have the leading test to determine whether or not the drug can be taken by a patient without it proving fatal so theoretically every new patient taking the drug should do one of our tests beforehand.

How the number if new users relates to the 2m number is anyone's guess as some won't get the prescription if the test comes back saying it is harmful, some will have taken it before and some will be unaware of the test.

It does show that it is a market worth addressing though

cash covering operating costs and forecast to continue growing going forward

10000 samples will be carried out in october and speaking to govt about moonshot

When would these air miles have been clocked up during a global lockdown?

"the group recorded it's first profits on an EBITDA level"

I know covid is exciting but let's not forget about the very strong core business

https://www.news-medical.net/amp/news/20200903/Improving-COVID-19-Diagnosis.aspx?__twitter_impression=true

The RNS mentions invoice discounting whereas companies house shows a collateralized loan.

What do people make of this facility that was taken out in mid April? If they need cash I would imagine that a placing would be high on their list of options after the recent strength. https://t.co/S3QVJVciTZ

After having spoken to AR and Mr Little at a previous presentation I think you are spot on the Nasdaq

Was expecting an RNS or at least an RNS Reach this am.

The bigger question has to be why another company is able to use it to produce covid tests get we let it sit idle.

RNS in, cash flow positive for H1 with positive outlook

Clearly lots of manufacturing work to go around, YGEN should be able to fill their boots

He thinks that people are more likely to abort if they get a test saying that their child has downs. Fact is people would still have a test, which is more dangerous, if NIPT wasn't available.

Once the trading update comes out the SP will take care of itself and this will come onto more people's radar other than the day traders

Govt is initially buying 3 5m tests https://www.theguardian.com/world/2020/mar/29/the-two-tests-that-will-help-to-predict-spread-of-covid-19

The vast majority of his tips have tanked, the chance to book a profit against this one must have seemed too tempting. He also seems to have ethical issues around NIPT. Each to their own, now his followers are out the SP should recover from here.

The company was set to make a profit this year before Coronavirus. Given the current market cap this has a long way to go up and a lot not yet priced in

17p fully diluted

This has proven to be a very leaky stock in the past so wouldn't be surprised if we hear some good news in the next few weeks